Global and Japan Normal Saline for Parenteral Use Market Insights, Forecast to 2027

Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.
This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection
At present, Baxter, Kelun Group, B. Braun, Fresenius Kabi and SSY Group are the top five manufacturers of gastrointestinal saline in the world, with a total market share of more than 45%.They are also the world's largest companies by sales.

Market Analysis and Insights: Global and Japan Normal Saline for Parenteral Use Market
This report focuses on global and Japan Normal Saline for Parenteral Use market.
In 2020, the global Normal Saline for Parenteral Use market size was US$ 3037.9 million and it is expected to reach US$ 3787.3 million by the end of 2027, with a CAGR of 3.2% during 2021-2027. In Japan the Normal Saline for Parenteral Use market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Normal Saline for Parenteral Use Scope and Market Size
Normal Saline for Parenteral Use market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Normal Saline for Parenteral Use market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Normal Saline for Parenteral Use market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Flexible Bag
Plastic Bottles
Glass Bottles

Segment by Application
Intramuscular Injection
Intravenous Injection
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Baxter
Pfizer
B. Braun
ICU Medical
Fresenius Kabi
Otsuka
Kelun Group
CR Double-Cran
SSY Group
Cisen Pharmaceutical
Denis Chem Lab Limited
Shree Krishnakeshav Laboratories
Pharmally International